Research output per year
Research output per year
Search results
-
2022
Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis
Kant, S., Azar, A. & Geetha, D., Feb 2022, In: Kidney international. 101, 2, p. 414-415 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Do the benefits of subcutaneous immunoglobulin therapy for secondary hypogammaglobulinemia in ANCA vasculitis extend beyond infection prevention?
Churilla, B. M., Aqeel, F., Azar, A., Antiochos, B., Seo, P., Hellmann, D. B. & Geetha, D., Aug 2022, In: Kidney international. 102, 2, p. 444-445 2 p.Research output: Contribution to journal › Letter › peer-review
-
2021
Correspondence on "sARS-CoV-2 vaccination in rituximab-treated patients: Evidence for impaired humoral but inducible cellular immune response" by Bonelli et al
Connolly, C. M., Koenig, D., Ravi, S. N., Azar, A., Kant, S., Dalal, M., Duchen, J., Seo, P., Antiochos, B., Paik, J. J. & Geetha, D., Oct 1 2021, In: Annals of the rheumatic diseases. 80, 10, e164.Research output: Contribution to journal › Letter › peer-review
-
Successful Desensitization to Febuxostat in a Patient with Hypersensitivity to Allopurinol and Febuxostat and Review of the Literature
Koenig, D., Royer, C. & Azar, A., Dec 1 2021, In: Journal of Clinical Rheumatology. 27, 8S, p. S432-S433Research output: Contribution to journal › Letter › peer-review
-
2008
Reversible panhypogammaglobulinemia associated with the antiepileptic agent levetiracetam
Azar, A. E. & Ballas, Z. K., Jul 2008, In: Annals of Allergy, Asthma and Immunology. 101, 1, p. 108-109 2 p.Research output: Contribution to journal › Letter › peer-review
10 Scopus citations -
The Reply:
Azar, A. E. & Ballas, Z. K., Mar 1 2008, In: American Journal of Medicine. 121, 3, p. e15Research output: Contribution to journal › Letter › peer-review